Human eosinophils express, relative to other circulating leukocytes, large amounts of secretory 14-kD phospholipase A2

Blood

Volumn 91, Issue 8, 1998, Pages 3037-3043

  Blom, M ^b   Tool, A T J ^b   Wever, P C ^b   Wolbink, G J ^b   Brouwer, M C ^b   Calafat, J ^b   Egesten, A ^b   Knol, E F ^b   Hack, C E ^b   Roos, D ^b   Verhoeven, A J ^a  

^a CENTRAL LABORATORY   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 5; MONOCLONAL ANTIBODY; PHOSPHOLIPASE A2; SECRETORY PROTEIN;

ARTICLE; ASTHMA; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; LEUKOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

BASOPHILS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EOSINOPHILS; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOCYTES; MONOCYTES; NEUTROPHILS; PHOSPHOLIPASES A;

EID: 0032522966     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Holgate ST, Roche WR, Church MK: The role of the eosinophil in asthma. Am Rev Respir Dis 143:S66, 1991 (suppl)
2. Corrigan CJ, Kay AB: T cells and eosinophils in the pathogenesis of asthma. Immunol Today 13:501, 1992
3. Jorg A, Henderson WR, Murphy RC, Klebanoff SJ: Leukotriene generation by eosinophils. J Exp Med 155:390, 1982
4. Lee T, Lenihan DJ, Malone B, Roddy LL, Wasserman SI: Increased biosynthesis of platelet-activating factor in activated human eosinophils. J Biol Chem 259:5526, 1984
5. Nieto ML, Velasco S, Crespo MS: Biosynthesis of platelet-activating factor in human polymorphonuclear leukocytes. J Biol Chem 263:2217, 1988
6. Motojima S, Frigas E, Loegering DA, Gleich GJ: Toxicity of eosinophil cationic protein for guinea-pig tracheal epithelium in vitro. Am Rev Respir Dis 139:801, 1989
7. Gleich GJ, Frigas E, Loegering DA, Wassom DL, Steinmuller D: Cytotoxic properties of eosinophil major basic protein. J Immunol 123:2925, 1979
8. Cuss FM, Dixon CM, Barnes PJ: Effects of platelet activating factor on pulmonar hyperresponsiveness in man. Lancet 2:189, 1986
9. Blom M, Tool ATJ, Kok PTM, Koenderman L, Roos D, Verhoeven AJ: Granulocyte-macrophage colony-stimulating factor, interleukin-3 (IL-3), and IL-5 greatly enhance the interaction of human eosinophils with opsonized particles by changing the affinity of complement receptor type 3. Blood 83:2978, 1994
10. 2. J Clin Invest 91:2118, 1993
11. 2(s); comparison of arachidonyl-selective and -nonselective enzymes. FASEB J 7:339, 1993
12. 2 gene family in mammals. J Biol Chem 272:17247, 1997
13. 2 at 2.2 Å resolution. Nature 352:79, 1991
14. 2 in human tissues. Inflammation 17:453, 1993
15. 2 enzyme activity associated with sepsis and septic shock is indistinguishable from that associated with rheumatoid arthritis. Inflammation 15:355, 1991
16. 2 from inflammatory exudate. Science 254:1007, 1991
17. 2S and characterization of their inflammatory activities. J Cell Biol 115:1445, 1991
18. 2 in human ascitic fluid. Biochem J 278:263, 1991
19. 1 macrophages. J Biol Chem 271:32381, 1996
20. 2 that mediates prostaglandin production in mast cells. J Biol Chem 272:13591, 1996
21. Koenderman L, Hamelink ML, Kok PTM, Verhoeven AJ, Bruijnzeel PLB: An improved method for the isolation of eosinophilic granulocytes from peripheral blood of normal individuals. J Leukoc Biol 44:79, 1989
22. de Boer M, Roos D: Metabolic comparison between basophils and other leukocytes from human blood. J Immunol 136:3447, 1986
23. Mul FPJ, Knol EF, Roos D: An improved method for the purification of basophilic granulocytes from human blood. J Immunol Methods 149:207, 1992
24. 2 in arthritis plasma using a newly developed sandwich ELISA. Br J Rheumatol 31:175, 1992
25. Reimert CM, Venge P, Kharazmi A, Bendtzen K: Detection of eosinophil cationic protein (ECP) by an enzyme-linked immunosorbent assay. J Immunol Methods 138:285, 1991
26. Olsson I, Venge P: Cationic proteins of human granulocytes. II. Separation of the cationic proteins of the granules of leukemic myeloid cells. Blood 44:235, 1974
27. 2 gene expression in human hepatoma cells by mediators of the acute phase response. J Biol Chem 266:2647, 1991
28. 2. Cancer Immunol Immunother 41:287, 1995
29. 2 in human polymorphonuclear leukocytes. Biochim Biophys Acta 879:149, 1986
30. 2. FASEB J 9:A225, 1996 (abstr)
31. 2 inhibitors suppress lysophosphatidylserine-dependent degranulation of rat peritoneal mast cells. Biochem Biophys Res Commun 181:714, 1991
32. Wright GC, Weiss J, Kim KS, Verheij H, Elsbach P: Bacterial phospholipid hydrolysis enhances the destruction of Escherichia coli ingested by rabbit neutrophils. J Clin Invest 85:1925, 1990
33. Bach MK, Brashler JR, Sanders ME, Bienkowski MJ: Pitfalls in the quantitative estimation of the secretion of granule proteins by eosinophils. J Immunol Methods 142:243, 1991
34. 2 in granules and secrete active enzyme in response to soluble stimuli. Biochem Biophys Res Commun 208:650, 1995
35. 2 activity in resting and activated human neutrophils. J Biol Chem 263:1929, 1988
36. 2 and arachidonate increase in bronchoalveolar lavage fluid after inhaled antigen challenge in asthmatics. Am J Respir Care Med 155:421, 1997
37. Peters SP: Mast cells and histamine in asthma. J Allergy Clin Immunol 86:642, 1990 (suppl)